ROME Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$149M
- Investors
-
15
ROME Therapeutics General Information
Description
Developer of novel therapies intended to cure cancer and autoimmune diseases. The company's therapies use the power of research and development processes backed by a team of leaders across fields including oncology, immunology, virology, and machine learning, enabling healthcare professionals to help patients get powerful new treatments for cancer and autoimmune diseases.
Contact Information
Website
www.rometx.comCorporate Office
- 201 Brookline Avenue
- Suite 1001
- Boston, MA 02215
- United States
Corporate Office
- 201 Brookline Avenue
- Suite 1001
- Boston, MA 02215
- United States
ROME Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 14-Aug-2023 | $149M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC (Series A) | 27-Apr-2020 | Completed | Pre-Clinical Trials |
ROME Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ROME Therapeutics Comparisons
Industry
Financing
Details
ROME Therapeutics Competitors (86)
One of ROME Therapeutics’s 86 competitors is Centrose, a Venture Capital-Backed company based in Middleton, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Middleton, WI | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Apexian Pharmaceuticals | Venture Capital-Backed | Indianapolis, IN | ||||
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Jubilant Therapeutics | Corporation | Allentown, PA |
ROME Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ROME Therapeutics Patents
ROME Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023255774-A1 | Didehydro-3'-deoxy-4'-ethynylthymidines and related compounds and their use in treating medical conditions | Pending | 22-Apr-2022 | ||
| EP-4511381-A1 | Didehydro-3'-deoxy-4'-ethynylthymidines and related compounds and their use in treating medical conditions | Pending | 22-Apr-2022 | ||
| US-20230295212-A1 | Compounds and methods for treating disease | Inactive | 15-Mar-2022 | ||
| US-20230374058-A1 | Compounds and methods for treating disease | Active | 15-Mar-2022 | ||
| AU-2023236711-A1 | Compounds and methods for treating disease | Pending | 15-Mar-2022 | C07H19/10 |
ROME Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ROME Therapeutics Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Andreessen Horowitz | Venture Capital | Minority | ||
| Bristol-Myers Squibb | Corporation | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Eurofarma Ventures | Corporate Venture Capital | Minority |
ROME Therapeutics FAQs
-
When was ROME Therapeutics founded?
ROME Therapeutics was founded in 2020.
-
Where is ROME Therapeutics headquartered?
ROME Therapeutics is headquartered in Boston, MA.
-
What is the size of ROME Therapeutics?
ROME Therapeutics has 48 total employees.
-
What industry is ROME Therapeutics in?
ROME Therapeutics’s primary industry is Drug Discovery.
-
Is ROME Therapeutics a private or public company?
ROME Therapeutics is a Private company.
-
What is the current valuation of ROME Therapeutics?
The current valuation of ROME Therapeutics is .
-
What is ROME Therapeutics’s current revenue?
The current revenue for ROME Therapeutics is .
-
How much funding has ROME Therapeutics raised over time?
ROME Therapeutics has raised $199M.
-
Who are ROME Therapeutics’s investors?
Alexandria Venture Investments, Andreessen Horowitz, Bristol-Myers Squibb, Casdin Capital, and Eurofarma Ventures are 5 of 15 investors who have invested in ROME Therapeutics.
-
Who are ROME Therapeutics’s competitors?
Centrose, Sorrento Therapeutics, Apexian Pharmaceuticals, NexImmune, and Jubilant Therapeutics are some of the 86 competitors of ROME Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
